Anti-counterfeit Pharmaceutical Packaging Market Report Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

 

Anti-counterfeit Pharmaceutical Packaging Market 

One of the key concerns raised is the role of packaging and its synergy with anti-counterfeit technology, which advocates packaging design to combat illicit use of packaged generic and branded drugs.

Several agencies, including the US Food and Drug Administration and the World Health Organization, enforce appropriate measures to prevent illegal drug channelling in the market, which drives the anti-counterfeit pharmaceutical packaging market growth. These initiatives encourage pharmaceutical companies to investigate new avenues. The anti-counterfeit pharmaceutical packaging market is responding positively, which is expected to continue throughout the forecast period.

One of the US-based companies has developed a new technology known as a "micro tag." which is an edible one used for medicine identification, authentication, brand protection, and quality assurance. Each tag contains a unique code that can only be scanned with the company's proprietary tools. Such technological advances continue to open doors for the anti-counterfeit pharmaceutical packaging market. During the forecast period, all of these factors are likely to contribute to the revolutionization of anti-counterfeit pharmaceutical packaging products. As an example,

Geographically, the anti-counterfeit pharmaceutical packaging market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Because of the strong presence of major key players in the region, North America is expected to account for the largest share of the market. Furthermore, the Asia Pacific market is expected to grow at the fastest rate during the forecast period, owing to consumer awareness of what they are purchasing prior to consumption.